What is LDXHF stock price today?

LDXHF (Lumos Diagnostics Holdings Limited) stock is trading at $0.13 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LDXHF stock going up or down today?

LDXHF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LDXHF stock now?

The decision to buy LDXHF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LDXHF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LDXHF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LDXHF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LDXHF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LDXHF's P/E ratio?

P/E ratio data for LDXHF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LDXHF's market cap?

LDXHF (Lumos Diagnostics Holdings Limited) has a market capitalization of $0.12 billion, making it a small-cap stock.

What is LDXHF's price to book ratio?

LDXHF trades at a price-to-book (P/B) ratio of 22.49, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LDXHF pay dividends?

LDXHF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LDXHF's dividend yield?

LDXHF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LDXHF stock a good long-term investment?

LDXHF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LDXHF's revenue growth rate?

LDXHF has shown revenue growth of -0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

LDXHF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in LDXHF?

Key risks for LDXHF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LDXHF compare to its competitors?

Compare LDXHF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LDXHF's performance and positioning.

What is LDXHF's stock price target for 2026?

Our AI model provides price targets for LDXHF based on fundamental analysis: Bull case $0.17 (+30%), Base case $0.15 (+15%), Bear case $0.12 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LDXHF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LDXHF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LDXHF's next earnings report?

LDXHF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LDXHF - Lumos Diagnostics Holdings Limited

NYSE * Healthcare * Medical Devices

$0.13

+$0.00 (+0.39%)

About Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.

LDXHF Key Statistics

Market Cap

$117.64M

P/B Ratio

22.49

EPS

$-0.01

Revenue Growth

-0.0%

Profit Margin

-0.8%

How LDXHF Compares to Peers

LDXHF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LDXHF(This stock)	$117.64M	N/A	-0%	-0.8%	-
ABTAbbott Laboratories	$176.48B	27.2	0%	0.1%	vs ABT
MDTMedtronic Plc	$111.83B	24.3	0%	0.1%	vs MDT
SYKStryker Corp	$130.69B	40.7	0%	0.1%	vs SYK
BSXBoston Scientific	$96.02B	33.3	0%	0.1%	vs BSX
ISRGIntuitive Surgical	$166.35B	59.7	0%	0.3%	vs ISRG

Lumos Diagnostics Holdings Limited Company Information

Headquarters: 2724 Loker Ave West, Carlsbad, CA, United States, 92010, undefined
Website: lumosdiagnostics.com
Sector: Healthcare
Industry: Medical Devices

About Lumos Diagnostics Holdings Limited

LDXHF Key Statistics

How LDXHF Compares to Peers

Lumos Diagnostics Holdings Limited Company Information

Upcoming Events for LDXHF